Babesiosis

Infectious Disease Clinics of North America

Volumn 29, Issue 2, 2015, Pages 357-370

  Vannier, Edouard G ^a   Diuk Wasser, Maria A ^b   Ben Mamoun, Choukri ^c   Krause, Peter J ^c,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Apicomplexa; Babesia microti; Babesiosis; Erythrocyte; Protozoan; Tick; Transfusion

Indexed keywords

ARTEMISININ; ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; DIETHYLTOLUAMIDE; DOXYCYCLINE; IMMUNOGLOBULIN G; PERMETHRIN; PHTHALIC ACID DIMETHYL ESTER; QUININE; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; PROTOZOAL DNA;

ANTIBODY TITER; ARTICLE; BABESIA MICROTI; CELL INVASION; CLINICAL FEATURE; CYTOLYSIS; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG RESPONSE; ERYTHROCYTE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INCUBATION TIME; IXODES; LABORATORY DIAGNOSIS; NONHUMAN; PARASITE IDENTIFICATION; PARASITE VIRULENCE; PATHOGENESIS; PHYLOGENY; PIROPLASMOSIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROTECTIVE CLOTHING; SEROLOGY; TICK; TICK BITE; TREATMENT DURATION; BABESIA; BABESIOSIS; ISOLATION AND PURIFICATION; PARASITOLOGY; TRANSMISSION;

ANTI-BACTERIAL AGENTS; BABESIA; BABESIOSIS; DNA, PROTOZOAN; ENZYME INHIBITORS; ERYTHROCYTES; HUMANS; POLYMERASE CHAIN REACTION;

EID: 84929617132     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2015.02.008     Document Type: Review

References (62)

1. Skrabalo A., Deanovic A. Piroplasmosis in man: report on a case. Doc Med Geogr Trop 1957, 9:11-16.
2. Vannier E., Krause P.J. Human babesiosis. N Engl J Med 2012, 366:2397-2407.
3. Hunfeld K.P., Hildebrandt A., Gray J.S. Babesiosis: recent insights into an ancient disease. Int J Parasitol 2008, 38:1219-1237.
4. Spielman A., Wilson M.L., Levine J.F., et al. Ecology of Ixodes dammini borne human babesiosis and Lyme disease. Annu Rev Entomol 1985, 30:439-460.
5. Cornillot E., Hadj-Kaddour K., Dassouli A., et al. Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti. Nucleic Acids Res 2012, 1-13.
6. Cornillot E., Dassouli A., Garg A., et al. Whole genome mapping and re-organization of the nuclear and mitochondrial genomes of Babesia microti isolates. PLoS One 2013, 8.
7. Goethert H.K., Telford S.R. What is Babesia microti?. Parasitology 2003, 127:301-309.
8. Nakajima R., Tsuji M., Oda K., et al. Babesia microti-group parasites compared phylogenetically by complete sequencing of the CCTeta gene in 36 isolates. J Vet Med Sci 2009, 71:55.
9. Fujisawa K., Nakajima R., Jinnai M., et al. Intron sequences from the CCT7 gene exhibit diverse evolutionary histories among the four lineages within the Babesia microti-group, a genetically related species complex that includes human pathogens. Jpn J Infect Dis 2011, 64:403-410.
10. Dunn J., Krause P.J., Davis S., et al. Borrelia burgdorferi promotes the establishment of Babesia microti in the northeastern United States. PLoS One 2014, 9(12):e115494.
11. Diuk-Wasser M., Liu L., Steeves T., et al. Monitoring human babesiosis emergence through vector surveillance New England USA. Emerg Infect Dis 2014, 20:225-231.
12. Krause P.J., McKay K., Gadbaw J., et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 2003, 68:431-436.
13. Piesman J., Spielman A. Human babesiosis on Nantucket Island: Prevalence of Babesia microti in ticks. Am J Trop Med Hyg 1980, 29:742-746.
14. Herwaldt B.L., Linden J.V., Bosserman E., et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011, 155:509-519.
15. Leiby D.A. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev 2011, 24:14-28.
16. Cornett J.K., Malhotra A., Hart D. Vertical transmission of babesiosis from a pregnant, splenectomized mother to her neonate. Infect Dis Clin Practice 2012, 20:408-410.
17. Joseph J.T., Purtill K., Wong S.J., et al. Vertical transmission of Babesia microti, United States. Emerg Infect Dis 2012, 18:1318-1321.
18. Joseph J.T., Roy S.S., Shams N., et al. Babesiosis in lower Hudson Valley, New York, USA. Emerg Infect Dis 2011, 17:843-847.
19. Krause P.J., Telford S.R., Ryan R., et al. Geographical and temporal distribution of babesial infection in Connecticut. J Clin Microbiol 1991, 29:1-4.
20. White D.J., Talarico J., Chang H.G., et al. Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998, 158:2149-2154.
21. Herwaldt B.L., Montgomery S., Woodhall D., Bosserman E.A. Babesiosis surveillance - 18 States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61:505-509.
22. Jiang J.F., Zheng Y.C., Jiang R.R., et al. Epidemiological, clinical, and laboratory characteristics of 48 cases of "Babesia venatorum" infection in China: a descriptive study. Lancet Infect Dis 2014, [pii:S1473-3099(14) 71046-1].
23. Vannier E., Krause P.J. Babesiosis in China, an emerging threat. Lancet Infect Dis 2014, 10.1016/S1473-3099(14)71062-X.
24. Krause P.J., Lepore T., Sikand V.J., et al. Atovaquone and azithromycin for the treatment of human babesiosis. N Engl J Med 2000, 343:1454-1458.
25. Ruebush T.K., Cassaday P.B., Marsh H.J., et al. Human babesiosis on Nantucket Island: clinical features. Ann Intern Med 1977, 86:6-9.
26. Krause P.J., Telford S.R., Spielman A., et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 1996, 275:1657-1660.
27. Krause P.J., McKay K., Thompson C.A., et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis 2002, 34:1184-1191.
28. Hatcher J.C., Greenberg P.D., Antique J., et al. Severe babesiosis in Long Island: Review of 34 cases and their complications. Clin Infect Dis 2001, 32:1117-1125.
29. Wittner M., Rowin K.S., Tanowitz H.B., et al. Successful chemotherapy of transfusion babesiosis. Ann Intern Med 1982, 96:601-604.
30. Krause P.J., Spielman A., Telford S., et al. Persistent parasitemia after acute babesiosis. N Engl J Med 1998, 339:160-165.
31. Krause P.J., Gewurz B.E., Hill D., et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis 2008, 46:370-376.
32. Thompson C., Spielman A., Krause P.J. Coinfecting deer associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. Clin Infect Dis 2001, 33:676-685.
33. Lobo C.A., Rodriguez M., Cursino-Santos J.R. Babesia and red cell invasion. Curr Opin Hematol 2012, 19:170-175.
34. Clark I.A., Jacobson L.S. Do babesiosis and malaria share a common disease process?. Ann Trop Med Parasitol 1998, 92:483-488.
35. Krause P.J., Daily J., Telford S.R., et al. Shared features in the pathobiology of babesiosis and malaria. Trends Parasitol 2007, 23:605-610.
36. Shaio M.F., Lin P.R. A case study of cytokine profiles in acute human babesiosis. Am J Trop Med Hyg 1998, 58:335-337.
37. Igarashi I., Waki S., Ito M., et al. Role of CD4+ T cells in the control of primary infection with Babesia microti in mice. J Protozool Res 1994, 4:164-171.
38. Hemmer R.M., Ferrick D.A., Conrad P.A. Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1. Parasitol Res 2000, 86:121-128.
39. Clark I.A., Budd A.C., Hsue G., et al. Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient. Malar J 2006, 5:69.
40. Terkawi M.A., Cao S., Herbas M.S., et al. Macrophage is the determinant of resistance to and outcome of non-lethal Babesia microti infection in mice. Infect Immun 2014, [Epub ahead of print].
41. Krause P.J., Telford S.R., Pollack R.J., et al. Babesiosis: an underdiagnosed disease of children. Pediatrics 1992, 89:1045-1048.
42. Vannier E., Borggraefe I., Telford S.R., et al. Age-associated decline in resistance to Babesia microti is genetically determined. J Infect Dis 2004, 189:1721-1728.
43. Krause P.J., Telford S.R., Spielman A., et al. Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia. J Clin Microbiol 1996, 34:2791-2794.
44. Teal A.E., Habura A., Ennis J., et al. A new real-time PCR assay for improved detection of the parasite Babesia microti. J Clin Microbiol 2012, 50:903-908.
45. Rollend L., Bent S.J., Krause P.J., et al. Quantitative PCR for detection of Babesia microti in Ixodes scapularis ticks and in human blood. Vector Borne Zoonotic Dis 2013, 13:784-790.
46. Bloch E.M., Lee T.H., Krause P.J., et al. Development of a real-time PCR assay for sensitive detection and quantitation of Babesia microti infection. Transfusion 2013, 53:2299-2306.
47. Krause P.J., Telford S., Ryan R., et al. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis 1994, 169:923-926.
48. Levin A.E., Williamson P.C., Erwin J.L., et al. Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion 2014, 54:2237-2244.
49. Kjemtrup A.M., Conrad P.A. Human babesiosis: an emerging tick-borne disease. Int J Parasitol 2000, 30:1323-1337.
50. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1089-1094.
51. Spaete J., Patrozou E., Rich J.D., et al. Red cell exchange transfusion for babesiosis in RhodeIsland. J Clin Apher 2009, 24:97-105.
52. Raoult D., Soulayrol L., Toga B., Dumon H., Casanova P. Babesiosis, pentamidine, and cotrimoxazole. Ann Intern Med 1987, 107:944.
53. Finch C., Al-Damluji M.S., Krause P.J., et al. Integrated assessment of behavioral and environmental risk factors for Lyme disease infection on Block Island, Rhode Island. PLoS One 2014, 9:e84758.
54. Stafford K.C. Tick management handbook: an integrated guide for homeowners, pest control operators, and public health officials for the prevention of tick-associated disease 2007, 1-77. The Connecticut Agricultural Experimental Station, New Haven (CT).
55. Connally N.P., Durante A.J., Yousey-Hindes K.M., et al. Peridomestic Lyme disease prevention: results of a population-based case-control study. Am J Prev Med 2009, 37:201-206.
56. Dister S.W., Fish D., Bros S.M., et al. Landscape characterization of peridomestic risk for Lyme disease using satellite imagery. Am J Trop Med Hyg 1997, 57:687-692.
57. Fish D., Childs J.E. Community-based prevention of Lyme disease and other tick-borne diseases through topical application of acaricide to white-tailed deer: background and rationale. Vector Borne Zoonotic Dis 2009, 9:357-364.
58. Wilson M.L., Telford S.R., Piesman J., Spielman A. Reduced abundance of immature Ixodes dammini (Acari: Ixodidae) following elimination of deer. J Med Entomol 1988, 25:224-228.
59. Kilpatrick H.J., Labonte A.M., Stafford K. The relationship between deer density, tick abundance, and human cases of Lyme disease in a residential community. J Med Entomol 2014, 51:777-784.
60. Young C., Chawla A., Berardi V., et al. Preventing transfusion transmitted babesiosis: Preliminary experience of the first laboratory-based blood donor screening program. Transfusion 2012, 52:1523-1529.
61. Goodell A., Bloch E.M., Krause P.J., et al. Costs, consequences, and cost-effectiveness of strategies for Babesia microti blood donor screening strategies the US blood supply. Transfusion 2014, 54:2245-2257.
62. Johnson S.T., Cable R.G., Leiby D.A. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion 2012, 52:1509-1516.